Products for Research Use Only
RegisterLogin

MRE-269

CAT: 0013-GTR19170110-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19170110-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MRE-269 (ACT-333679) is the long-acting, orally active metabolite of Selexipag and a potent prostacyclin receptor (IP receptor) agonist. It is utilized in pulmonary arterial hypertension (PAH) research, with studies demonstrating its efficacy in both in vitro assays and in vivo animal models of pulmonary hypertension.
CAS Number
475085-57-5
Product Name Alternative
ACT 333679, ACT-333679, ACT333679, MRE 269, MRE269, MRE-269, inhibit, Inhibitor, ProstaglandinReceptor, prostaglandin I2 receptor, Prostaglandin Receptor
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.25% (May vary between batches)
Solubility
DMSO:55 mg/mL (131.1 mM) ;10% DMSO+90% Corn Oil:2.5 mg/mL (5.96 mM)
Smiles
N (CCCCOCC (O) =O) (C (C) C) C=1N=C (C (=NC1) C2=CC=CC=C2) C3=CC=CC=C3
Molecular Formula
C25H29N3O3
Molecular Weight
419.52
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR17965002Mre-11 Antibody
GTR19163871-01TMP-269
GTR19258474-01Anticancer agent 269
GTR19258228-01Antibacterial agent 269
GTR19275261-01CRBN ligand-269
GTR17698184ACAT1 (aa257-269) Antibody
GTR18902192-01Sugen Kinase 269 peptide
GTR17698456ACAT1 (aa257-269), Biotinylated Antibody
GTR18988128ACAT1 (aa257-269) Immunizing Peptide
GTR18048099-01Sugen Kinase 269 polyclonal antibody

Alternative Products

CatalogName
456637-01MRE-269
HY-79593S1-01MRE-269-d6
HY-79593S2-01MRE-269-d7
456641-01MRE-269-d8
HY-79593R-01MRE-269 (Standard)
456640-01MRE-269-d10
C11380-5mgMRE-269 (ACT-333679)
456639MRE-269 β-D-Glucuronide
HY-79593S3MRE-269-d7 (sodium)
A18322-100MRE-269 (ACT-333679) 100mg

Popular Products